SCHEMBL15528700

SCHEMBL15528700

COC(=O)c1ccccc1NC(=O)c1ccco1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 4/20 1.00
▸ KDM4E B2RXH2 10/20 0.74
▸ HSD17B10 Q99714 6/20 0.74
▸ ALDH1A1 P00352 6/20 0.70
▸ TSHR P16473 4/20 0.70
▸ MAPT P10636 3/20 0.70
▸ NPSR1 Q6W5P4 2/20 0.70
▸ HPGD P15428 1/20 0.70
▸ KMT2A Q03164 4/20 0.68
▸ MEN1 O00255 2/20 0.68
▸ L3MBTL1 Q9Y468 2/20 0.68
▸ POLB P06746 2/20 0.68
▸ MAPK10 P53779 1/20 0.68
▸ CRHBP P24387 1/20 0.67
▸ CRHR2 Q13324 1/20 0.67
▸ USP2 O75604 1/20 0.64
▸ GPR55 Q9Y2T6 1/20 0.63
▸ LMNA P02545 1/20 0.62
▸ PKM P14618 1/20 0.61
▸ RECQL P46063 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16384115 0.91 MAPK1 (0.83) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL31087262 0.85 MAPK1 (0.74) MAPK1KDM4EHSD17B10TSHRMAPT
SCHEMBL15528812 0.83 MAPK1 (0.71) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6638013 0.81 TSHR (0.73) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6638142 0.78 ATM (0.77) MAPK1KDM4EALDH1A1TSHRMAPT
SCHEMBL6717150 0.78 MAPK1 (0.64) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL23413018 0.77 KMT2A (0.76) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL8802200 0.77 TSHR (0.84) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6242064 0.76 TSHR (0.80) MAPK1KDM4EHSD17B10ALDH1A1TSHR
SCHEMBL6635707 0.76 SMN1; SMN2 (0.69) MAPK1KDM4EALDH1A1TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2844345-B1 MODULATORS OF THE RELAXIN RECEPTOR 1 US HEALTH (US) 2022-08-03 — — EP disclosed
US-10125112-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2018-11-13 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA AS REPRESENTED BY SECRETARY DEPT OF HEALTH AND HUMAN SERVICE (US) 2017-05-25 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-9452973-B2 Modulators of the relaxin receptor 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-09-27 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES 2015-04-30 — — US disclosed
EP-2844345-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 The United States of America, as Represented by The Secretary, Department of Health and Human Services (US) 2015-03-11 — — EP disclosed
WO-2013165606-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2013-11-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119426-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 MAPK1 1480/4885KDM4E 4395/4885HSD17B10 2635/4885
US-10125112-B2 Modulators of the relaxin receptor 1 RXFP1, RXFP2, RXFP3 MAPK1 1480/4885KDM4E 4395/4885HSD17B10 2635/4885
US-20170144984-A1 MODULATORS OF THE RELAXIN RECEPTOR 1 RXFP1, RXFP2, RXFP3 MAPK1 1480/4885KDM4E 4395/4885HSD17B10 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback